OMERS Administration Corp’s Quest Diagnostics DGX Stock Holding History

OMERS Administration Corp’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.28M	Buy	11,640 +10,073	+643%	+$1.96M	0.01%	480
2025 Q4	$272K	Buy	+1,567	New	+$285K	﹤0.01%	834
2017 Q4	–	Sell	-29,793	Closed	-$2.79M	–	420
2017 Q3	$2.79M	Buy	29,793 +15,100	+103%	+$1.6M	0.03%	229
2017 Q2	$1.63M	Buy	+14,693	New	+$1.55M	0.02%	252
2016 Q4	–	Sell	-57,700	Closed	-$4.88M	–	383
2016 Q3	$4.88M	Hold	57,700	–	–	0.09%	148
2016 Q2	$4.7M	Buy	+57,700	New	+$4.39M	0.1%	151
2014 Q3	–	Sell	-4,300	Closed	-$252K	–	363
2014 Q2	$252K	Buy	+4,300	New	+$252K	0.01%	349

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

OMERS Administration Corp's DGX Position: Q1 2026 in Review

OMERS Administration Corp increased its Quest Diagnostics (DGX) stake by 643% in Q1 2026, buying an estimated $1.96M and bringing the position to 11,640 shares worth $2.28M. The position accounts for 0.01% of the portfolio, ranked #480.

OMERS Administration Corp first reported a position in DGX in Q2 2014 and has held it in 7 quarters since. The position peaked at $4.88M in Q3 2016. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

OMERS Administration Corp held 11,640 shares of Quest Diagnostics worth $2.28M as of Q1 2026.
OMERS Administration Corp bought 10,073 Quest Diagnostics shares in Q1 2026, an estimated $1.96M.
Quest Diagnostics made up 0.01% of OMERS Administration Corp's portfolio in Q1 2026, its #480 holding.
OMERS Administration Corp first reported a position in Quest Diagnostics in Q2 2014 and has held it in 7 quarters since.
OMERS Administration Corp's Quest Diagnostics position peaked at $4.88M in Q3 2016.
1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.